NCT07648771
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
Not Yet Recruiting
Not specifiedAges 18+ObservationalStanford UniversityInvestigator-initiated
~800 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Ketamine (Ketalar)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in PROMIS Pain Interference Score From Baseline
Measured over From enrollment to 16 weeks after the ketamine infusion
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Planning to receive an intravenous ketamine infusion for the treatment of chronic pain
Exclusion
Unable to read or understand English questionnaires
What this trial measures
- Change in PROMIS Pain Interference Score From BaselineFrom enrollment to 16 weeks after the ketamine infusion